FDA Approves Unknown Drug — QUAGEN
Quagen has secured FDA approval for its application (ANDA 204649), a move expected to enhance the company's market position by increasing generic supply and bolstering competition against branded incumbents.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day